
    
      Aptinib combined with TACE can be generated through embolization and angiogenesis by the dual
      target of vascular suppression.Efficacy and safety of apatinib combined with TACE in patients
      with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.
    
  